Drug maker Lupin on Wednesday said a court in Europe has upheld a decision to impose a fine of 40 million euros (over Rs 325 crore) on the company by the European Commission (EC) in a litigation over blood pressure lowering drug, Perindopril.

The Mumbai-based company said the General Court of the European Union has delivered its judgement concerning Lupin’s and other companies’ appeals against the EC’s 2014 decision in the Perindopril litigation.

“The General Court upheld the EC’s decision holding Lupin liable to pay a fine of euro 40 million,” the company said in a regulatory filing. The company added that it would study the court’s judgement and evaluate a further course of action.

In 2014, Lupin and Unichem Laboratories were among six global drug makers on which the European regulator had imposed a collective fine of 427.7 million euros for striking deals to prevent entry of cheaper versions of blood pressure drug, Perindopril, in the EU.

Shares of the company on Wednesday ended 1.62 per cent down at Rs 821.85 on the BSE.

comment COMMENT NOW